Maria M. Lorenzo

Madrid, MD 28040, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat Resistance.

Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat Resistance.

Journal: Viruses
Published: December 21, 2024

Evaluation of Vaccinia Virus Infection in Mice Using Two-Reporter Recombinant Virus.

Evaluation of Vaccinia Virus Infection in Mice Using Two-Reporter Recombinant Virus.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 02, 2024

Correction for Chiem et al., "Identification of In Vitro Inhibitors of Monkeypox Replication".

Correction for Chiem et al., "Identification of In Vitro Inhibitors of Monkeypox Replication".

Journal: Microbiology spectrum
Published: December 06, 2023

Identification of In Vitro Inhibitors of Monkeypox Replication.

Identification of In Vitro Inhibitors of Monkeypox Replication.

Journal: Microbiology spectrum
Published: June 06, 2023

Antivirals against monkeypox infections.

Antivirals against monkeypox infections.

Journal: bioRxiv : the preprint server for biology
Published: May 03, 2023

Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models.

Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models.

Journal: Vaccines
Published: April 14, 2023

Identification of β2 microglobulin, the product of B2M gene, as a Host Factor for Vaccinia Virus Infection by Genome-Wide CRISPR genetic screens.

Identification of β2 microglobulin, the product of B2M gene, as a Host Factor for Vaccinia Virus Infection by Genome-Wide CRISPR genetic screens.

Journal: PLoS pathogens
Published: August 10, 2022

Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.

Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.

Journal: Microbiology spectrum
Published: May 18, 2022

Bi-Reporter Vaccinia Virus for Tracking Viral Infections In Vitro and In Vivo.

Bi-Reporter Vaccinia Virus for Tracking Viral Infections In Vitro and In Vivo.

Journal: Microbiology spectrum
Published: November 24, 2021

Tools for the targeted genetic modification of poxvirus genomes.

Tools for the targeted genetic modification of poxvirus genomes.

Journal: Current opinion in virology
Published: October 02, 2020

Genes A27L and F13L as Genetic Markers for the Isolation of Recombinant Vaccinia Virus.

Genes A27L and F13L as Genetic Markers for the Isolation of Recombinant Vaccinia Virus.

Journal: Scientific reports
Published: August 07, 2019

Vaccinia virus and Cowpox virus are not susceptible to the interferon-induced antiviral protein MxA.

Vaccinia virus and Cowpox virus are not susceptible to the interferon-induced antiviral protein MxA.

Journal: PloS one
Published: April 27, 2017
Showing 1-12 of 16

Last Updated: 09/26/2026